Table 2 Demographic characteristics of LT recipients
|  | Total (n = 51) |
|---|---|
No. patients (pediatric/adult)a | 13/38 |
Age at LT [median (range)] | |
 Pediatric | 12 m (5–50 m) |
 Adult | 50.5 y (18–66 y) |
Sex (male/female) | 19/32 |
Living donor/brain death donor | 38/13 |
ABO-incompatible | 8 (15.7%) |
Underlying disease | |
 Biliary atresia | 10 (19.6%) |
 Primary sclerosing cholangitis | 9 (17.6%) |
 Primary biliary cholangitis | 6 (11.8%) |
 Fulminant hepatic failure | 6 (11.8%) |
 Hepatitis B | 4 (7.8%) |
 Hepatitis C | 4 (7.8%) |
 Autoimmune hepatitis | 3 (5.9%) |
 Others | 11 (21.6%) |
ACR | 19 (37.3%) |
Days from LT to ACR [median (range)] | 8 (4–56) |
Days of hospitalization after LT [median (range)] | 62 (24–326) |